Overview

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Use of dexmedetomidine in pituitary tumor resection surgery as adjuvant drug and its relation to cortisol levels during postoperative period.
Phase:
Phase 4
Details
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Treatments:
Cortisol succinate
Dexmedetomidine
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate